Westside Investment Management’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Westside Investment Management's INMB Position: Q2 2026 in Review
Westside Investment Management held its INmune Bio (INMB) position steady in Q2 2026 at 108,300 shares worth $177K. The position accounts for 0.02% of the portfolio, ranked #330.
Westside Investment Management first reported a position in INMB in Q4 2021 and has held it in 19 quarters since. The position peaked at $697K in Q1 2025. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.
- Westside Investment Management held 108,300 shares of INmune Bio worth $177K as of Q2 2026.
- Westside Investment Management left its INmune Bio share count unchanged in Q2 2026.
- INmune Bio made up 0.02% of Westside Investment Management's portfolio in Q2 2026, its #330 holding.
- Westside Investment Management first reported a position in INmune Bio in Q4 2021 and has held it in 19 quarters since.
- Westside Investment Management's INmune Bio position peaked at $697K in Q1 2025.
- 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.